SCHEMBL248688

SCHEMBL248688

CC(=O)Oc1ccccc1CCl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.52
KDM4E B2RXH2 2/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 2/20 0.52
ESR1 P03372 1/20 0.52
ITGB3 P05106 1/20 0.52
ITGA2B P08514 1/20 0.52
HMGB1 P09429 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
GGT1 P19440 1/20 0.52
PTGS1 P23219 1/20 0.52
BLM P54132 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPT P10636 2/20 0.44
HSP90AA1 P07900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30997189 1.00 PTGS2 (0.52) PTGS2KDM4EHSD17B10ALDH1A1ESR1
Benzene SCHEMBL3150461 0.98 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
Naphthalene SCHEMBL3155078 0.95 PTGS2 (0.47) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL4328045 0.89 HSD17B10 (0.65) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL609102 0.84 CXCL8 (0.40) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL11589528 0.84 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL68677 0.84 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL30850062 0.84 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL10924111 0.82 PTGS2 (0.53) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL3628841 0.82 PTGS2 (0.53) PTGS2KDM4EHSD17B10ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820200-A Heterobivalent compound taking piperidinoindenone-salicylic acid as parent, and preparation method and application thereof 合肥工业大学 2024-04-05 CN claimed
CN-102297924-B High performance liquid chromatography method for analyzing impurity content of ortho-tolylacetic acid and 2-chloromethyl phenylacetic acid in 3-isochromanone SHANGHAI NO 4 REAGENT & H V CHEMICAL CO LTD 2013-10-30 CN claimed
CN-102297924-A High performance liquid chromatography method for analyzing impurity content of ortho-tolylacetic acid and 2-chloromethyl phenylacetic acid in 3-isochromanone 2011-12-28 CN claimed
CN-1303079-C Process for the preparation of 3-isochromanone SYNGENTA LTD (GB) 2007-03-07 CN claimed
CN-1653058-A Process for the preparation of 3-isochromanone SYNGENTA LTD (GB) 2005-08-10 CN claimed
CN-1102590-C Process for preparing 3-isochromanone ZENECA LTD (GB) 2003-03-05 CN claimed
CN-1222150-A Process for preparing 3-isochromanone ZENECA LTD (GB) 1999-07-07 CN claimed
EP-4323330-B1 PROCESS FOR THE PREPARATION OF HIGHLY PURE SALCAPROZIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF NAVINTA III INC (US) 2025-12-10 EP disclosed
US-12454506-B2 Benzoate derivatives ZHEJIANG YUEJIA PHARMACEUTICALS CO., LTD (CN) 2025-10-28 US disclosed
US-20250243177-A1 sGC STIMULATORS CYCLERION THERAPEUTICS, INC. 2025-07-31 US disclosed
US-20250229198-A1 COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I (CZ) 2025-07-17 US disclosed
CN-120117987-A Arylalkanoic acid phloroglucinol ester compound, preparation method and application thereof 南华大学 2025-06-10 CN disclosed
CN-119874493-A Novel method for synthesizing alpha, beta-unsaturated ketone 广西大学 2025-04-25 CN disclosed
US-4264771-A Alkylation of substituted oxazolinone-(5) compounds BASF AKTIENGESELLSCHAFT (DE) 1981-04-28 US disclosed
US-4255336-A Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01 CIBA-GEIGY CORPORATION (US) 1981-03-10 US disclosed
EP-0003274-A1 o-Substituted (+)-cyanidan-3-ol derivatives, method for their preparation, as well as pharmaceutical compositions containing these compounds and their preparation Zyma SA (CH) 1979-08-08 EP disclosed
US-4024160-A Substituted 2-amino chromones and process for the preparation thereof WARNER-LAMBERT COMPANY (US) 1977-05-17 US disclosed
US-3993661-A Quinone methide photograhpic reagent precursors POLAROID CORPORATION (US) 1976-11-23 US disclosed
US-3932466-A Substituted 2-amino chromones and process for the preparation thereof WARNER-LAMBERT COMPANY (US) 1976-01-13 US disclosed
US-3932480-A PHOTOGRAPHY POLAROID CORPORATION (US) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12454506-B2 Benzoate derivatives NFKBIA, NFKB2, NFKB1 PTGS2 74/4885KDM4E 522/4885HSD17B10 445/4885
US-20250229198-A1 COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF SCO2, SOD3, SLC39A3 PTGS2 2129/4885KDM4E 4827/4885HSD17B10 3211/4885
US-20250243177-A1 sGC STIMULATORS GUCY1A1, PTGIS, GUCY1B1 PTGS2 20/4885KDM4E 2445/4885HSD17B10 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.